Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_assertion type Assertion NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_head.
- NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_assertion description "[A substantial percentage of brain tumors overexpressed biomarkers associated with drug resistance, including MGMT (67%), GSTP1 (49%), and mutant p53 (41%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_provenance.
- NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_assertion evidence source_evidence_literature NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_provenance.
- NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_assertion SIO_000772 16899598 NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_provenance.
- NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_assertion wasDerivedFrom befree-20140225 NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_provenance.
- NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_assertion wasGeneratedBy ECO_0000203 NP776690.RAxa0DB5P4TJh7Gu_DOpvMBlnukfOmlux1biWt2QdROp4130_provenance.